Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1997;30:1544-1548

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ho, C. S.
Right arrow Articles by Swaminathan, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ho, C. S.
Right arrow Articles by Swaminathan, R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*DIGOXIN
*DOPAMINE
*OUABAIN
*SODIUM

(Hypertension. 1997;30:1544-1548.)
© 1997 American Heart Association, Inc.


Articles

Effect of Carbidopa on the Excretion of Sodium, Dopamine, and Ouabain-Like Substance in the Rat

Chung Shun Ho; Asif Butt; Yemane K. Semra; ; R. Swaminathan

From the Department of Chemical Pathology, Prince of Wales Hospital, Shatin, NT, Hong Kong (C.S.H.) and the Department of Chemical Pathology, UMDS, Guy's & St Thomas' Hospital, London, UK (A.B., Y.K.S., R.S.).

Correspondence to Prof R. Swaminathan, Department of Chemical Pathology, United Medical & Dental Schools, St Thomas' Hospital, London, SE1 7EH UK. E-mail r.swaminathan{at}umds.ac.uk

Abstract The effect of carbidopa, a competitive inhibitor of dopamine synthesis on the excretion of sodium, dopamine (DA), and endogenous sodium transport inhibitor (ESTI), was examined in rats on normal and high salt diets for 7 days. ESTI activity was measured (1) as ouabain-like substance (OLS) by radioimmunoassay using an antibody raised against ouabain, (2) by inhibition of purified Na+,K+-ATPase activity (ATPI), and (3) as digoxin-like substance (DLS) using a commercial digoxin assay. The OLS immunoassay was validated against rubidium transport studies. High salt diet caused an increase in OLS and ATPI but not DLS. Sodium excretion in rats on normal sodium intake was not affected by carbidopa treatment but was significantly lower in the high sodium diet group during the first 5 days of the study. In the low salt group, carbidopa treatment caused significant increases in OLS. We conclude that ESTI (measured as OLS) and DA are important in the natriuresis of salt loading.


Key Words: dopamine • sodium • ouabain • carbidopa • sodium transport inhibitor, endogenous




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
A. Y. Bagrov, J. I. Shapiro, and O. V. Fedorova
Endogenous Cardiotonic Steroids: Physiology, Pharmacology, and Novel Therapeutic Targets
Pharmacol. Rev., March 1, 2009; 61(1): 9 - 38.
[Abstract] [Full Text] [PDF]